higher order crossover methodology [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2020-06-30 20:17 (1367 d 06:47 ago) – Posting: # 21623
Views: 6,372

Ah,

it is all coming together now.

Thanks sweiner,
this is a great question.:-)

❝ In a 5-way BE crossover trial, is there a methodology available that allows one to analyze 3 out of 5 sequences for BE in an interim fashion, and contingent upon results complete the remaining 2 sequences and analyze all 5 sequences at the conclusion?


Should read: "In a 5-way BE crossover trial, is there a methodology available that allows one to analyze 3 out of 5 periods for BE in an interim fashion, and contingent upon results complete the remaining 2 periods and analyze all 5 periods at the conclusion?"

This is an interesting idea, one that has not been explored much yet in the public domain; I think a few other sponsors have used it.
It is definitely doable as a single protocol. It is in fact what other companies / sponsors are achieving with two separate studies. Just do it, I think it may not require much operational adjustment or statistical fiddling, unless you can say you will switch to another formulation and re-start another 5-period trial once the first formulation fails after 3 periods.

A great post, in my opinion.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
68 visitors (0 registered, 68 guests [including 10 identified bots]).
Forum time: 02:04 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5